Skip to main content

Table 3 Questionnaire outcomes summarised by pathology group, excluding those reporting rheumatoid arthritis (n = 690)

From: Ultrasound-detected pathologies cluster into groups with different clinical outcomes: data from 3000 community referrals for shoulder pain

  Bursitis (limited inflammation) (n = 291) Bursitis (extensive inflammation) (n = 177) RC tear (n = 122) Limited pathology (n = 100)
Percentage of sample 40% 39% 33% 42%
Age, years, mean (SD) 49.9 (11.1) 64.8 (9.2) 67.1 (10.4) 47.5 (12.6)
Female sex, % 63 45 47 55
Smoker, % 40 39 33 42
Comorbidity count, median (IQR) 1 (0–2) 2 (1–2) 2 (1–3) 1 (0–2)
Painful sites count (including target), median (IQR) 3 (1–6) 3 (1–7) 3 (1–6) 2 (1–4)
Follow-up, months, median (IQR) 26 (23–29) 26 (22–29) 25 (23–29) 24 (21–26)
Had shoulder fracture before scan, % 2 2 <1 1
Had shoulder dislocation before scan, % 1 4 1
Had breast/shoulder cancer before scan, % <1
Had major injury to target shoulder before scan, % 7 8 18 3
Had shoulder fracture since scan, % <1 1 1
Had shoulder dislocation since scan, % <1
Had breast/shoulder cancer since scan, % <1 <1
Had major injury to target shoulder since scan, % 1 2 7 1
Had physiotherapy since scan, % 65 62 59 58
Had injection since scan, % 76 67 48 61
Had more than one injection since scan, % 33 30 22 24
Had surgery since scan, % 23 21 28 16
Still has shoulder pain, % 63 63 77 64
If still in pain     
 Pain duration, months, median (IQR) 24 (12–36) 21 (12–36) 25 (12–36) 24 (18–36)
 Has pain-free periods, % 70 77 72 77
 Experiences pain on moving in a certain way, % 91 93 92 85
If not still in pain     
 How long since last had pain, months, median (IQR) 12 (6–17) 13 (12–20) 12 (6–18) 12 (10–20)
 How long did pain last, months, median (IQR) 9 (3–15) 9 (5–18) 12 (12–18) 6 (4–12)
Symptoms at time of questionnaire     
 SPADI pain, median (IQR) 34 (4–62) 26 (2–62) 48 (18–66) 32 (6–64)
 SPADI difficulty, median (IQR) 13 (0–45) 14 (0–43) 30 (10–54) 9 (0–38)
 SPADI total, median (IQR) 24 (3–52) 21 (3–51) 41 (15–59) 25 (5–49)
 Shoulder activity score, median (IQR) 6 (3–10) 6 (3–10) 5 (3–9) 7 (4–11)
 EQ-5D health index score, median (IQR) 0.8 (0.6–0.8) 0.7 (0.6–0.8) 0.7 (0.5–0.8) 0.8 (0.7–0.8)
 EQ-5D VAS, median (IQR) 80 (55–90) 80 (60–90) 75 (60–80) 80 (70–90)
 EQ-5D anxiety or depression (>0), % 34 30 40 29
 Depression reported in comorbidity list, % 17 14 18 14
 Difficulty standing from sitting (>1), % 16 20 21 10
  1. EQ-5D EuroQol five dimensions scale, SPADI Shoulder Pain and Disability Index, VAS Visual analogue scale
  2. Data were not available for all outcomes for all survey responders; see Additional file 1: Table S8 for numbers of patients with data available